|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film). |
| 公司地址
| 10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235 |
| 電話號碼
| +1 804 379-1040 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.indivior.com |
| 員工數量
| 838 |
| Ms. Kathryn Barbara Hudson |
Company Secretary |
-- |
01/07/2025 |
| Mr. Ryan Preblick |
Executive Director,Chief Financial Officer |
美元 539.90K |
01/07/2025 |
| Mr. Joe Ciaffoni |
Executive Director,Chief Executive Officer |
-- |
30/05/2025 |
|
|
| Mr. Daniel A. Ninivaggi |
Non-Executive Director |
03/02/2025 |
| Mr. Robert A. Schriesheim |
Non-Executive Director |
01/07/2025 |
| Mr. Mark Stejbach |
Non-Executive Director |
01/07/2025 |
| Mr. Stuart Anthony Kingsley |
Non-Executive Director |
01/07/2025 |
| Dr. Peter James Jonathan Bains |
Non-Executive Director |
01/07/2025 |
| Ms. Juliet Thompson |
Non-Executive Director,Senior Independent Director |
01/07/2025 |
| Ms. Joanna Susan Le Couilliard |
Non-Executive Director |
01/07/2025 |
| Dr. David E. Wheadon, M.D. |
Non-Executive Director,Chairman |
28/01/2025 |
| Mr. Ryan Preblick |
Executive Director,Chief Financial Officer |
01/07/2025 |
| Ms. Barbara Ryan |
Non-Executive Director |
01/07/2025 |
| Mr. Keith Humphreys OBE |
Non-Executive Director |
01/07/2025 |
| Mr. Joe Ciaffoni |
Executive Director,Chief Executive Officer |
30/05/2025 |
|
|
|
|
